Clinical Breast Cancer

Article	Citations
The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)	960115767
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial	132
Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study	92
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer	81
Cancer-related Fatigue in Breast Cancer Survivors: A Review	66
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer	43
Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study	42
Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial	40
Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer	38
Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI	36
Epidemiology of De Novo Metastatic Breast Cancer	35
Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019	35
Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression	33
Can Breast Self-examination and Clinical Breast Examination Along With Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations With Advanced Stages at Diagnosis?	30
Thermal Ablation as an Alternative for Surgical Resection of Small (≤ 2 cm) Breast Cancers: A Meta-Analysis	29
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study	28
Association Between One-carbon Metabolism-related Vitamins and Risk of Breast Cancer: A Systematic Review and Meta-analysis of Prospective Studies	27
Circulating Biomarkers in Breast Cancer	27
Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction	27
Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons	27
Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis	26
A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer	26
Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis	26
Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers	24
Advances in Combining Radiation and Immunotherapy in Breast Cancer	24

MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT	24
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer	23
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer	22
circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1	22
Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis	21
Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses	21
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022	21
Breast Conserving Surgery for BRCA Mutation Carriers—A Systematic Review	21
Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy	21
MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)	20
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer	20
Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry	19
MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions	19
Regret and Quality of Life After Mastectomy With or Without Reconstruction	19
Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up	19
Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI	18
Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization	18
Complications in Post-mastectomy Immediate Breast Reconstruction: A Ten-year Analysis of Outcomes	18
Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated Wit	18
A Review of Breast Density Implications and Breast Cancer Screening	18
Controversial role of mast cells in breast cancer tumor progression and angiogenesis	18
Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial	18
Birth Weight and Incidence of Breast Cancer: Dose-Response Meta-analysis of Prospective Studies	17
Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative S	17
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer	17
Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis	17
Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis	17
Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer	16
Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing	16
Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction	16
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer	16
Advances in Therapeutic Approaches for Triple-Negative Breast Cancer	16
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach	16
Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study	16
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPA	15
Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review	15
Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study	15
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review	15
Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues	15
Clinical Features and Survival of Single Hormone Receptor–Positive Breast Cancer: A Population-Based Study of 531,605 Patients	14
Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach	14
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer	14
Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials	14
Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer	13
Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer	13
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment	13
Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer	13
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast	13
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study	13
Nuances of PFKFB3 Signaling in Breast Cancer	13

Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort	13
Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study	12
Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions	12
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer	12
Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction	12
Interventional Ductoscopy as an Alternative for Major Duct Excision or Microdochectomy in Women Suffering Pathologic Nipple Discharge: A Single-center Experience	12
The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis	12
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies	12
Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema	12
Prevention of Breast Cancer-Related Lymphedema	12
Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study	12
Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography	12
Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast	12
Network Meta-analysis for the Diagnostic Approach to Pathologic Nipple Discharge	11
Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy	11
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors	11
The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy	11
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity	11
YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer	11
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy	11
Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review	11
Neuromuscular, Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients	11
Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Liter	11
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)	11
Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2	11
Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes	11
Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database	11
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer	10
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)	10
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study	10
Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data	10
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis	10
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy	10
The Role of Contrast-Enhanced Ultrasound in the Diagnosis and Pathologic Response Prediction in Breast Cancer: A Meta-analysis and Systematic Review	10
Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis	10
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer	10
The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis	9
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity	9
Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients	9
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy	9
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer	9
Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical Considerations	9
Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan	9
Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population	9
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer	9
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine	9
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients	9
The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer	9
An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening	9
Bone-modifying Agents (BMAs) in Breast Cancer	9
Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy	9
CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers	9
Intraoperative Ultrasound and Oncoplastic Combined Approach: An Additional Tool for the Oncoplastic Surgeon to Obtain Tumor-Free Margins in Breast Conservative Surgery—A 2-Year Single-Center Prospecti	9
Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections	9
Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer	9
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis	9
Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer	8
Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression	8
A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ	8
Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer	8
Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?	8
AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer	8
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data	8
The Effects of HER2 on CDK4/6 Activity in Breast Cancer	8
Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey	8
Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature	8
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer	8
Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography	8
Werner Syndrome Protein Expression in Breast Cancer	8
MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer	8
Ultrasound and Clinical Characteristics of False-negative Results in Mammography Screening of Dense Breasts	8
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study	7
The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data	7
Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3	7
Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor–Positive Breast Cancers: Is It Prognostic?	7
Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer	7
Comparison of Spinal Alignment and Mobility in Women With and Without Post Modified Radical Mastectomy Unilateral Lymphoedema	7
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer	7
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic	7
Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer	7

Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT	7
Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer	7
Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis	7
Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis	7
Current Status and Problems of Breast Cancer Treatment with Schizophrenia	7
Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study	7
RUNX1 as a Novel Molecular Target for Breast Cancer	7
Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells	7
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study	7
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study	7
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer	7
Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival	7
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review	7
Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization	7
Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors	7
Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?	7
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy	7
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction	7
A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer	7
Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans	7
The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis	7
Predicting Mastectomy Skin Flap Necrosis: A Systematic Review of Preoperative and Intraoperative Assessment Techniques	6
Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis	6
Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival	6
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay	6
Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers	6
Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells	6
Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy	6
Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method)	6
Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018	6
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution	6
A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer	6
Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database	6
Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions	6
Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer	6
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies	6
Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison	6
Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer	6
Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016	6
The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review	6
A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women	6
Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy	6
Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling	6
Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery	6
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer	6
New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab	6
First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis	6
Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users	6
The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study	6
Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide	6
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer	6
Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center	6
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer	5
Adherence to the DASH Diet and Risk of Breast Cancer	5
Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy	5
Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis	5
Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions	5
Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources	5
Relation Between Early Disturbance of lymphatic transport Visualized With Lymphofluoroscopy and Other Clinical Assessment Methods in Patients With Breast Cancer	5
Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells	5
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer	5
En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome	5
Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis	5
Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery	5
Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study	5
Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment	5
Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer	5
Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program	5
Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology	5
Big Data Solutions for Controversies in Breast Cancer Treatment	5
Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer	5
Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment	5
Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction	5
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence	5
Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance	5
Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients	5
Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy	5
Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?	5
Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study	5
Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study	5
Added Value of Different Types of Elastography in Evaluating Ultrasonography Detected Breast Lesions: A Compared Study With Mammography	5
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer	5
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy	5
Prospective Clinical Trial on Expanding Indications for Cryosurgery for Early Breast Cancers	5
Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of Breast Cancer in Australian Caucasian Women	5
Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups	5
Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study	5
FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway	5
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)	5
Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast	5
Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study	5
Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and Reconstruction	5
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy	5
Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy	5
Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer	5